Trials / Completed
CompletedNCT05539976
A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
An Open-label Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 25 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to develop taste profiles of iberdomide and mezigdomide drug substances and oral formulation prototypes in order to develop a pediatric oral form of iberdomide and mezigdomide.
Conditions
Timeline
- Start date
- 2022-09-30
- Primary completion
- 2022-11-14
- Completion
- 2022-11-14
- First posted
- 2022-09-14
- Last updated
- 2022-12-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05539976. Inclusion in this directory is not an endorsement.